Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02309736

OTX-14-002: Device Exposure Registry

Device Exposure Registry: A Post-Approval Observational Registry of ReSure Sealant to Track the Incidence of Endophthalmitis After Sealing Corneal Incisions in Patients Undergoing Clear Corneal Cataract Surgery

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Ocular Therapeutix, Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions

Conditions

Interventions

TypeNameDescription
DEVICEReSure Sealant

Timeline

Primary completion
2020-04-01
First posted
2014-12-05
Last updated
2020-02-05

Source: ClinicalTrials.gov record NCT02309736. Inclusion in this directory is not an endorsement.

OTX-14-002: Device Exposure Registry (NCT02309736) · Clinical Trials Directory